Kook Jin Kuk Chun

Dr. Kook Jin Kuk Chun

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
WKWoochan Kwon
Woochan Kwon
JLJoo Myung Lee
Joo Myung Lee
KYKyeong Ho Yun
Kyeong Ho Yun
KCKi Hong Choi
Ki Hong Choi
SLSeung-Jae Lee
Seung-Jae Lee
FIfor The RENOVATE COMPLEX-PCI Investigators
for The RENOVATE COMPLEX-PCI Investigators
BACKGROUND: The RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance Versus Angiography-Guidance on Clinical Outcomes After Complex Percutaneous Coronary Intervention) demonstrated that intravascular imaging–guided percutaneous coronary intervention (PCI) improved clinical outcome compared with angiography-guided PCI for patients with complex coronary artery lesions. This study aims to assess whether the prognostic benefit of intravascular imaging–guided procedural optimization persists in patients undergoing PCI for left main coronary artery disease. METHODS: Of 1639 patients enrolled in the RENOVATE-COMPLEX-PCI, 192 patients with left main coronary artery disease were selected for the current prespecified substudy. Selected patients were randomly assigned to either the intravascular imaging–guided PCI group (n=138) or the angiography-guided PCI group (n=54). The primary end point was target vessel failure defined as a composite of cardiac death, target vessel–related myocardial infarction, or clinically driven target vessel revascularization. RESULTS: At a median follow-up of 2.1 years (interquartile range 1.1 to 3.0 years), intravascular imaging–guided PCI was associated with lower incidence of primary end point compared with angiography-guided PCI (6.8% versus 25.1%; hazard ratio, 0.31 [95% CI, 0.13–0.76]; P =0.010). This significant reduction in primary end point was mainly driven by a lower risk of cardiac death or spontaneous target vessel–related myocardial infarction (1.6% versus 12.7%; hazard ratio, 0.16 [95% CI, 0.03–0.82]; P =0.028). Intravascular imaging–guided PCI was independently associated with a lower risk of primary end point, even after adjusting for various clinical factors (hazard ratio, 0.29 [95% CI, 0.12–0.72]; P =0.007). CONCLUSIONS: Intravascular imaging–guided PCI showed clinical benefit over angiography-guided PCI for left main coronary artery disease in reducing the risk of cardiac death, target vessel–related myocardial infarction, or target vessel revascularization. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03381872.

1 January 2021 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
SLSoo Yong Lee
Soo Yong Lee
TLTae Wook Lee
Tae Wook Lee
GPGyutae Park
Gyutae Park
JKJae Ho Kim
Jae Ho Kim
HLHyun-Chae Lee
Hyun-Chae Lee
JHJin Hur
Jin Hur
Korean Circulation Journal 대한심장학회지 순환기 Lee SY, et al. Korean Circ J. 2020 Oct;51:e15. https://doi.org/10.4070/kcj.2020.0303

9 March 2022 in JAMA Cardiology
Verified
Journal Article
Open access
PDF file
DHDoyeon Hwang
Doyeon Hwang
YLYoung-Hyo Lim
Young-Hyo Lim
KPKyung Woo Park
Kyung Woo Park
KCKook Jin Kuk Chun
Kook Jin Kuk Chun
JHJung-Kyu Han
Jung-Kyu Han
YSYoung Bin Song
Young Bin Song
In patients with acute coronary syndrome (ACS) receiving percutaneous coronary intervention (PCI), a potent P2Y12 inhibitor–based dual antiplatelet therapy (DAPT) is currently recommended as standard therapy.1 However, the benefits of potent P2Y12 inhibitors on ischemic outcomes come at the cost of increased bleeding risk.2,3 Considering that bleeding events are associated with a higher risk of mortality, we should not overlook the bleeding risk when deciding on the DAPT strategy.4 In a recent randomized trial,5 a de-escalation strategy of antiplatelet therapy by reducing the dose of prasugrel at 1 month post-PCI reduced net adverse clinical outcomes compared with maintaining the conventional dose of prasugrel. The benefit was driven by a significant reduction of bleeding without any increase in ischemic events. However, whether such benefits are similarly observed in those receiving complex PCI is unknown.

31 March 2014 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
KCKook Jin Kuk Chun
Kook Jin Kuk Chun
SLSang-Gwon Lee
Sang-Gwon Lee
BSBong Soo Son
Bong Soo Son
DKDo Hyung Kim
Do Hyung Kim
Acupuncture as an ancient Chinese treatment has proven effective and is utilized worldwide. Although it is generally believed to be a safe clinical procedure, serious lethal complications including death have been reported. We present a rare case of life-threatening cardiac tamponade due to penetration of an acupuncture needle directly into the right ventricle.

28 August 2013 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
PDF file
JKJeong Su Kim
Jeong Su Kim
CKChang Hoon Kim
Chang Hoon Kim
KCKook Jin Kuk Chun
Kook Jin Kuk Chun
JKJune-Hong Kim
June-Hong Kim
YPYong Hyun Park
Yong Hyun Park
MJMyung Ho Jeong
Myung Ho Jeong

1 January 2016 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
JHJongmin Hwang
Jongmin Hwang
KCKook Jin Kuk Chun
Kook Jin Kuk Chun
DLDae Sung Lee
Dae Sung Lee
SLSoo Yong Lee
Soo Yong Lee
MCMin Ku Chon
Min Ku Chon
JKJune Hong Kim
June Hong Kim
Hwang J, et al. Korean Circ J. 2016 Nov;46(6):862-865. https://doi.org/10.4070/kcj.2016.46.6.862